Literature DB >> 11273936

A lack of evidence of superiority of propofol versus midazolam for sedation in mechanically ventilated critically ill patients: a qualitative and quantitative systematic review.

B Walder1, N Elia, I Henzi, J R Romand, M R Tramèr.   

Abstract

UNLABELLED: Propofol and midazolam are often used for sedation in the intensive care unit. The aim of this systematic review was to estimate the efficacy and harm of propofol versus midazolam in mechanically ventilated patients. A systematic search (Medline, Cochrane Library, Embase, bibliographies), any language, up to June 1999 was performed for reports of randomized comparisons of propofol with midazolam. Data from 27 trials (1624 adults) were analyzed. The average duration of sedation varied between 4 and 339 h. In 10 trials, the duration of adequate sedation was longer with propofol (weighted mean difference 2.9 h; 95% confidence interval [CI], 0.2-5.6 h). In 13 trials (mostly postoperative), sedation lasted 4 to 35 h; in 9 of those, average weaning time from mechanical ventilation with propofol was 0.8-4.3 h; with midazolam it was 1.5-7.2 h (weighted mean difference 2.2 h [95% CI, 0.8 to 3.7 h]). In 8 trials, sedation lasted 54 to 339 h; there was a lack of evidence for difference in weaning times. Arterial hypotension (relative risk 2.5 [95% CI, 1.3 to 4.5]; number-needed-to-treat, 12), and hypertriglyceridemia (relative risk 12.1 [95%CI, 2.9 to 49.7]; number-needed-to-treat, 6) occurred more often with propofol. The duration of adequate sedation time is longer with propofol compared with midazolam. In postoperative patients with sedation <36 h, weaning is faster with propofol. IMPLICATIONS: The duration of adequate sedation time is longer with propofol compared with midazolam. In postoperative patients with sedation < 36 h, weaning is faster with propofol.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11273936     DOI: 10.1097/00000539-200104000-00033

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  10 in total

1.  The use of propofol for medium and long-term sedation in critically ill adult patients: a meta-analysis.

Authors:  Kwok M Ho; Joseph Y Ng
Journal:  Intensive Care Med       Date:  2008-06-25       Impact factor: 17.440

Review 2.  Sedation for critically ill or injured adults in the intensive care unit: a shifting paradigm.

Authors:  Derek J Roberts; Babar Haroon; Richard I Hall
Journal:  Drugs       Date:  2012-10-01       Impact factor: 9.546

3.  Long-term sedation in intensive care unit: a randomized comparison between inhaled sevoflurane and intravenous propofol or midazolam.

Authors:  Malcie Mesnil; Xavier Capdevila; Sophie Bringuier; Pierre-Olivier Trine; Yoan Falquet; Jonathan Charbit; Jean-Paul Roustan; Gerald Chanques; Samir Jaber
Journal:  Intensive Care Med       Date:  2011-03-29       Impact factor: 17.440

4.  Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care--short version.

Authors:  Jörg Martin; Anja Heymann; Katrin Bäsell; Ralf Baron; Rolf Biniek; Hartmut Bürkle; Peter Dall; Christine Dictus; Verena Eggers; Ingolf Eichler; Lothar Engelmann; Lars Garten; Wolfgang Hartl; Ulrike Haase; Ralf Huth; Paul Kessler; Stefan Kleinschmidt; Wolfgang Koppert; Franz-Josef Kretz; Heinz Laubenthal; Guenter Marggraf; Andreas Meiser; Edmund Neugebauer; Ulrike Neuhaus; Christian Putensen; Michael Quintel; Alexander Reske; Bernard Roth; Jens Scholz; Stefan Schröder; Dierk Schreiter; Jürgen Schüttler; Gerhard Schwarzmann; Robert Stingele; Peter Tonner; Philip Tränkle; Rolf Detlef Treede; Tomislav Trupkovic; Michael Tryba; Frank Wappler; Christian Waydhas; Claudia Spies
Journal:  Ger Med Sci       Date:  2010-02-02

5.  Propofol or benzodiazepines for short- and long-term sedation in intensive care units? An economic evaluation based on meta-analytic results.

Authors:  Lorenzo Pradelli; Massimiliano Povero; Hartmut Bürkle; Tim-Gerald Kampmeier; Giorgio Della-Rocca; Astrid Feuersenger; Jean-Francois Baron; Martin Westphal
Journal:  Clinicoecon Outcomes Res       Date:  2017-11-09

Review 6.  Psychotropic drug therapy in patients in the intensive care unit - usage, adverse effects, and drug interactions: a review.

Authors:  Mojtaba Shafiekhani; Mahtabalsadat Mirjalili; Afsaneh Vazin
Journal:  Ther Clin Risk Manag       Date:  2018-09-28       Impact factor: 2.423

7.  Sedation in the intensive care setting.

Authors:  Christopher G Hughes; Stuart McGrane; Pratik P Pandharipande
Journal:  Clin Pharmacol       Date:  2012-10-25

8.  Midazolam and propofol used alone or sequentially for long-term sedation in critically ill, mechanically ventilated patients: a prospective, randomized study.

Authors:  Yongfang Zhou; Xiaodong Jin; Yan Kang; Guopeng Liang; Tingting Liu; Ni Deng
Journal:  Crit Care       Date:  2014-06-16       Impact factor: 9.097

9.  Alpha-2 agonists for sedation in mechanically ventilated neurocritical care patients: a systematic review protocol.

Authors:  Alexandre Tran; Henrietta Blinder; Brian Hutton; Shane English
Journal:  Syst Rev       Date:  2016-09-08

Review 10.  Evidence and consensus based guideline for the management of delirium, analgesia, and sedation in intensive care medicine. Revision 2015 (DAS-Guideline 2015) - short version.

Authors:  Ralf Baron; Andreas Binder; Rolf Biniek; Stephan Braune; Hartmut Buerkle; Peter Dall; Sueha Demirakca; Rahel Eckardt; Verena Eggers; Ingolf Eichler; Ingo Fietze; Stephan Freys; Andreas Fründ; Lars Garten; Bernhard Gohrbandt; Irene Harth; Wolfgang Hartl; Hans-Jürgen Heppner; Johannes Horter; Ralf Huth; Uwe Janssens; Christine Jungk; Kristin Maria Kaeuper; Paul Kessler; Stefan Kleinschmidt; Matthias Kochanek; Matthias Kumpf; Andreas Meiser; Anika Mueller; Maritta Orth; Christian Putensen; Bernd Roth; Michael Schaefer; Rainhild Schaefers; Peter Schellongowski; Monika Schindler; Reinhard Schmitt; Jens Scholz; Stefan Schroeder; Gerhard Schwarzmann; Claudia Spies; Robert Stingele; Peter Tonner; Uwe Trieschmann; Michael Tryba; Frank Wappler; Christian Waydhas; Bjoern Weiss; Guido Weisshaar
Journal:  Ger Med Sci       Date:  2015-11-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.